Pressure BioSciences, Inc. PBIO
Set alert
At close · Oct 30
- YTD
- -60.00%
- 1 year
- -75.00%
- Open
- 0.0398
- Prev close
- 0.0005
- Mkt cap
- 8.19K
- Vol
- 800
- Avg vol
- 6.37K
- EPS
- -0.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0398
- High
- 0.0398
- Forward P/E
- 0.00
- Beta
- 2.21
- Short ratio
- 3.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 4.00
- 200-d avg
- 6.37
- 1y target
- 1.57
6M chart
Signals (29)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| MACD: Sell Signal | Oct 30, 2026 | 2 days ago |
| RSI: Oversold | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 15, 2026 | 3 months ago |
| RSI: Oversold | Jul 10, 2026 | 3 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| RSI: Overbought | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| MACD: Buy Signal | May 5, 2026 | 6 months ago |
Key statistics
- Market cap
- 4.94M
- Enterprise value
- 14.11M
- Trailing P/E
- -1.19
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 2.41
- Price / book
- 0.00
- EPS (TTM)
- -3.77
- Beta
- 2.21
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -190.38%
- Revenue (TTM)
- 2.05M
- Revenue growth
- 5.80%
- Free cash flow
- -3.48M
- Total cash
- 201.33K
- Total debt
- 9.69M
- Return on equity
- 0.00%
- Shares outstanding
- 1.10M
- Short % of float
- 4.56%
- 50-day average
- 4.00
- 200-day average
- 6.37
Analyst view
Consensus: none
Next earnings
Dec 23, 2024
Expected Dec 23, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Sep 6, 2024 | Mar 1, 2024 | 0.00 | -0.22 | — | — |
| Jun 7, 2024 | Dec 1, 2023 | 0.00 | -0.30 | — | — |
| Nov 20, 2023 | Sep 1, 2023 | 0.00 | -0.29 | — | — |
| Aug 21, 2023 | Jun 1, 2023 | 0.00 | -0.57 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2013 | Merriman Capital | init | — | Speculative Buy |
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions in the United States. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes Constant Systems cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Appliances & Equipment
- Country
- United States
- Website
- pressurebiosciences.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PBIO — it syncs with the Stock Master app.